Literature DB >> 27230856

Subcortical matter in the α-synucleinopathies spectrum: an MRI pilot study.

S Gazzina1, E Premi1, R Turrone1, J Acosta-Cabronero2, M C Rizzetti3, M S Cotelli4, R Gasparotti5, A Padovani6, B Borroni7.   

Abstract

α-Synucleinopathies, such as Parkinson's disease (PD) and dementia with Lewy bodies (DLB), are characterized by α-synuclein accumulation from brainstem structures to the neocortex. PD and DLB are clinically distinguishable, while discrimination between Parkinson Disease Dementia (PDD) and DLB can be subtle and based on the temporal relationship between motor and cognitive symptoms. To explore patterns of subcortical atrophy in PD, PDD and DLB, and assess specific differences between PD and PDD, and between DLB and PDD. 16 PD, 11 PDD and 16 DLB patients were recruited and underwent 1.5 Tesla structural MRI scanning. Segmentation of subcortical structures was performed with a well-validated, fully-automated tool, and volume and shape for each structure were compared between groups. PDD and DLB patients showed global subcortical atrophy compared to PD patients. Greater hippocampal atrophy was the specific trait that distinguished PDD from PD, while greater atrophy of the pallidi discriminated DLB from PDD. Vertex analysis revealed specific shape differences in both structures. Our results suggest that automated, time-sparing, subcortical volumetry may provide diagnostically useful information in α-synucleinopathies. Future studies on larger samples and with iron-sensitive MRI contrasts are needed.

Entities:  

Keywords:  Basal ganglia; FIRST; Lewy body dementia; Parkinson disease

Mesh:

Substances:

Year:  2016        PMID: 27230856     DOI: 10.1007/s00415-016-8173-5

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  41 in total

1.  Alpha-synuclein cortical Lewy bodies correlate with dementia in Parkinson's disease.

Authors:  H I Hurtig; J Q Trojanowski; J Galvin; D Ewbank; M L Schmidt; V M Lee; C M Clark; G Glosser; M B Stern; S M Gollomp; S E Arnold
Journal:  Neurology       Date:  2000-05-23       Impact factor: 9.910

Review 2.  New roles for the external globus pallidus in basal ganglia circuits and behavior.

Authors:  Aryn H Gittis; Joshua D Berke; Mark D Bevan; C Savio Chan; Nicolas Mallet; Michelle M Morrow; Robert Schmidt
Journal:  J Neurosci       Date:  2014-11-12       Impact factor: 6.167

Review 3.  Model-based interpretation of complex and variable images.

Authors:  C J Taylor; T F Cootes; A Lanitis; G Edwards; P Smyth; A C Kotcheff
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1997-08-29       Impact factor: 6.237

4.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

Authors:  A J Hughes; S E Daniel; L Kilford; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-03       Impact factor: 10.154

5.  Grey matter atrophy in cognitively impaired Parkinson's disease.

Authors:  Tracy R Melzer; Richard Watts; Michael R MacAskill; Toni L Pitcher; Leslie Livingston; Ross J Keenan; John C Dalrymple-Alford; Tim J Anderson
Journal:  J Neurol Neurosurg Psychiatry       Date:  2011-09-02       Impact factor: 10.154

Review 6.  Dementia associated with Parkinson's disease.

Authors:  Murat Emre
Journal:  Lancet Neurol       Date:  2003-04       Impact factor: 44.182

7.  The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia.

Authors:  J L Cummings; M Mega; K Gray; S Rosenberg-Thompson; D A Carusi; J Gornbein
Journal:  Neurology       Date:  1994-12       Impact factor: 9.910

8.  Gray matter atrophy in Parkinson disease with dementia and dementia with Lewy bodies.

Authors:  Mona K Beyer; Jan P Larsen; Dag Aarsland
Journal:  Neurology       Date:  2007-08-21       Impact factor: 9.910

9.  A comparison of automated segmentation and manual tracing for quantifying hippocampal and amygdala volumes.

Authors:  Rajendra A Morey; Christopher M Petty; Yuan Xu; Jasmeet Pannu Hayes; H Ryan Wagner; Darrell V Lewis; Kevin S LaBar; Martin Styner; Gregory McCarthy
Journal:  Neuroimage       Date:  2008-12-30       Impact factor: 6.556

10.  In Vivo MRI Mapping of Brain Iron Deposition across the Adult Lifespan.

Authors:  Julio Acosta-Cabronero; Matthew J Betts; Arturo Cardenas-Blanco; Shan Yang; Peter J Nestor
Journal:  J Neurosci       Date:  2016-01-13       Impact factor: 6.167

View more
  4 in total

Review 1.  Dementia with Lewy bodies and Parkinson's disease-dementia: current concepts and controversies.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2017-12-08       Impact factor: 3.575

2.  Extrastriatal dopaminergic and serotonergic pathways in Parkinson's disease and in dementia with Lewy bodies: a 123I-FP-CIT SPECT study.

Authors:  Andrea Pilotto; Francesca Schiano di Cola; Enrico Premi; Roberto Grasso; Rosanna Turrone; Stefano Gipponi; Andrea Scalvini; Elisabetta Cottini; Barbara Paghera; Valentina Garibotto; Maria Cristina Rizzetti; Laura Bonanni; Barbara Borroni; Silvia Morbelli; Flavio Nobili; Ugo Paolo Guerra; Daniela Perani; Alessandro Padovani
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-05-16       Impact factor: 9.236

3.  Are dementia with Lewy bodies and Parkinson's disease dementia the same disease?

Authors:  Kurt A Jellinger; Amos D Korczyn
Journal:  BMC Med       Date:  2018-03-06       Impact factor: 8.775

4.  Regional Structural Hippocampal Differences Between Dementia with Lewy Bodies and Parkinson's Disease.

Authors:  Laura J de Schipper; Anne Hafkemeijer; Jeroen van der Grond; Johan Marinus; Johanna M L Henselmans; Jacobus J van Hilten
Journal:  J Parkinsons Dis       Date:  2019       Impact factor: 5.568

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.